Progression of Nuclear Sclerosis and Long-term Visual Results of Vitrectomy With Transforming Growth Factor Beta-2 for Macular Holes
- 1 January 1995
- journal article
- Published by Elsevier BV in American Journal of Ophthalmology
- Vol. 119 (1), 48-54
- https://doi.org/10.1016/s0002-9394(14)73812-7
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Vitreous Surgery for Macular HolesOphthalmology, 1993
- Stage III macular hole surgery.British Journal of Ophthalmology, 1993
- The Effect of Pars Plana Vitrectomy and Transforming Growth Factor-Beta 2 without Epiretinal Membrane Peeling on Full-thickness Macular HolesOphthalmology, 1993
- TRANSFORMING GROWTH FACTOR-β2 SIGNIFICANTLY ENHANCES THE ABILITY TO FLATTEN THE RIM OF SUBRETINAL FLUID SURROUNDING MACULAR HOLESRetina, 1993
- The Absorption of Mixtures of Air and Perfluoropropane After Pars Plana VitrectomyAmerican Journal of Ophthalmology, 1992
- Transforming Growth Factor-β2 for the Treatment of Full-thickness Macular HolesOphthalmology, 1992
- Vitreous Surgery for Idiopathic Macular HolesAmerican Journal of Ophthalmology, 1991
- Nuclear Sclerotic Cataract After Vitrectomy for Idiopathic Epiretinal Membranes Causing Macular PuckerAmerican Journal of Ophthalmology, 1991
- Nuclear Sclerosis After Vitrectomy for Idiopathic Epiretinal MembranesAmerican Journal of Ophthalmology, 1988